(Q53059077)

11 May 2018

title

Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. (English)

1 reference

11 May 2018

1 reference

1

1 reference

11 May 2018

Beata Halassy

series ordinal

3

1 reference

11 May 2018

Lidija Habjanec

series ordinal

2

object named as

Lidija Habjanec

1 reference

11 May 2018

Jelka Tomasić

4

1 reference

11 May 2018

language of work or name

English

0 references

publication date

24 July 2009

1 reference

11 May 2018

published in

Vaccine

1 reference

11 May 2018

volume

27

1 reference

11 May 2018

issue

40

1 reference

11 May 2018

page(s)

5435-5442

1 reference

11 May 2018

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Liposomes as carriers of antigens and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Liposome-based cationic adjuvant formulations (CAF): past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

A simple but effective cancer vaccine consisting of an antigen and a cationic lipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Effect of Liposomal Formulations and Immunostimulating Peptidoglycan Monomer (PGM) on the Immune Reaction to Ovalbumin in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Cationic liposomes as in vivo delivery vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Cationic lipids, lipoplexes and intracellular delivery of genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Gene delivery by cationic lipids: in and out of an endosome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

DOTAP (and other cationic lipids): chemistry, biophysics, and transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

A dialkynoyl analogue of DOPE improves gene transfer of lower-charged, cationic lipoplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Entrapment of Ovalbumin into Liposomes—Factors Affecting Entrapment Efficiency, Liposome Size, and Zeta Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Adjuvant activity of peptidoglycan monomer and its metabolic products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Comparison of mouse and rabbit model for the assessment of strong PGM-containing oil-based adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Factors affecting microencapsulation of drugs in liposomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Spin-labelling study of interactions of ovalbumin with multilamellar liposomes and specific anti-ovalbumin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

DNA vaccines: ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Liposomal delivery of CTL epitopes to dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

Cationic liposomal lipids: from gene carriers to cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.012

10.1016/J.VACCINE.2009.07.012

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018